about
The responsiveness of TrkB to BDNF and antidepressant drugs is differentially regulated during mouse developmentAntidepressant drugs transactivate TrkB neurotrophin receptors in the adult rodent brain independently of BDNF and monoamine transporter blockadeRepeated brief isoflurane anesthesia during early postnatal development produces negligible changes on adult behavior in male miceDistinctive behavioral and cellular responses to fluoxetine in the mouse model for Fragile X syndrome.Effects of maternal smoking and exposure to methylmercury on brain-derived neurotrophic factor concentrations in umbilical cord serum.Utilization of in situ ELISA method for examining Trk receptor phosphorylation in cultured cells.Role of neurotrophic factors in depression.Cholesterol loss enhances TrkB signaling in hippocampal neurons aging in vitroThe impact of Bdnf gene deficiency to the memory impairment and brain pathology of APPswe/PS1dE9 mouse model of Alzheimer's disease.Role of brain-derived neurotrophic factor in the aetiology of depression: implications for pharmacological treatment.The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity.Antidepressant drug action--From rapid changes on network function to network rewiring.VGF (TLQP-62)-induced neurogenesis targets early phase neural progenitor cells in the adult hippocampus and requires glutamate and BDNF signaling.Brief Isoflurane Anesthesia Produces Prominent Phosphoproteomic Changes in the Adult Mouse Hippocampus.Isoflurane produces antidepressant effects and induces TrkB signaling in rodents.Brief isoflurane anesthesia regulates striatal AKT-GSK3β signaling and ameliorates motor deficits in a rat model of early-stage Parkinson's disease.Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampusBDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse.Regulation of brain-derived neurotrophic factor (BDNF) and cerebral dopamine neurotrophic factor (CDNF) by anti-parkinsonian drug therapy in vivo.Brain-derived neurotrophic factor controls activity-dependent maturation of CA1 synapses by downregulating tonic activation of presynaptic kainate receptors.The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice.Enhanced BDNF signaling is associated with an antidepressant-like behavioral response and changes in brain monoamines.P11 promoter methylation predicts the antidepressant effect of electroconvulsive therapy.NCAM-deficient mice show prominent abnormalities in serotonergic and BDNF systems in brain - Restoration by chronic amitriptyline.Darkness reduces BDNF expression in the visual cortex and induces repressive chromatin remodeling at the BDNF gene in both hippocampus and visual cortex.Sleep homeostasis and depression: studies with the rat clomipramine model of depression.Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain.Combined ipsilateral limb use score as an index of motor deficits and neurorestoration in parkinsonian rats.Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits.Nimodipine activates TrkB neurotrophin receptors and induces neuroplastic and neuroprotective signaling events in the mouse hippocampus and prefrontal cortex.The effects of acute and long-term lithium treatments on trkB neurotrophin receptor activation in the mouse hippocampus and anterior cingulate cortex.Impaired TrkB receptor signaling contributes to memory impairment in APP/PS1 mice.A role for BDNF/TrkB signaling in behavioral and physiological consequences of social defeat stress.Alterations in BDNF and phospho-CREB levels following chronic oral nicotine treatment and its withdrawal in dopaminergic brain areas of mice.Cortical Excitability and Activation of TrkB Signaling During Rebound Slow Oscillations Are Critical for Rapid Antidepressant ResponsesDyskinesia and brain-derived neurotrophic factor levels after long-term levodopa and nicotinic receptor agonist treatments in female mice with near-total unilateral dopaminergic denervationTargeting TrkB neurotrophin receptor to treat depressionSleep-State Dependent Alterations in Brain Functional Connectivity under Urethane Anesthesia in a Rat Model of Early-Stage Parkinson's DiseaseDual mechanism of TRKB activation by anandamide through CB1 and TRPV1 receptorsCommentary: Commonly Used Anesthesia/Euthanasia Methods for Brain Collection Differentially Impact MAPK Activity in Male and Female C57BL/6 Mice.
P50
Q27307753-6F572FBB-D907-4AF9-BB93-549220D1A4A5Q28478486-22DA2595-6CDC-40C7-8396-64EA711F1F2CQ30358430-0C9DAAC7-98FE-4B48-B21E-686400670D20Q33676486-BB8B959D-3F04-49C4-8BCA-A511422FED46Q34131881-3F07325A-DCB2-4160-92C8-7174A718AD95Q35044825-D7197D01-5EE7-4AED-BADD-5A01419E26F3Q36627683-328C9346-D53F-4EE5-A60C-4A369C89C614Q36631171-3819C352-1AFD-4D91-887E-814B879A9B22Q36980971-B20533E2-04E4-4122-A1CA-06ED77183B71Q37661474-E83EA07A-C7E3-4B8D-9494-351D54A11D51Q37699054-D71D5503-0415-4790-A194-65C41EF5B14EQ38525290-A5E7420A-1E8B-47C0-B333-881D042A8569Q39002821-2AFC78C2-E748-45C5-81D9-379EEA1F39E6Q39853800-5B52D35A-04E5-4104-99B4-1B66E4FEC4C6Q41354445-24953D7D-4D65-40FE-B8EE-DC26908CE9BCQ41551976-F6EF8DB9-5921-4B8D-B21C-11212E0E33FEQ41964356-1860E686-6259-4FC0-B745-095B4578CE0FQ42479365-AF04E482-C4E1-48BB-BC5B-05976E80377FQ43272193-2286A6F7-0D6D-4FAE-B45E-809E56962E97Q43278870-87C2CF72-8DBB-4AAB-B0C3-45CC74B261B2Q44026969-181D30EA-FA87-4D1E-94F0-2A7F99B8F746Q46878695-7387ADFB-7756-477F-9289-D10607E2C9DEQ47556643-821B412A-542A-4F5C-8663-4D4EC8DF3EB7Q48071906-732C242E-FA05-4C02-A82B-1ADD701B701AQ48135950-0B089526-356C-4E8A-8E48-56AA9BE41A97Q48248602-29F286FA-A2E9-4D09-8D7F-4058F1EF2213Q48266494-29822CFA-E330-4677-A6BB-5039B9D518E5Q48298593-48F559E3-996A-4F77-AF1A-62D98C0381A5Q48334323-CEED604B-973F-489F-B599-8293E0821406Q48554814-1B89771F-C5DA-4A7B-9FDA-FD76DBF760FAQ48689480-BC5BA3FB-4E2E-48C4-9A11-B199D408D08CQ48736054-E2AE0BE0-528A-4C27-9FD9-2B0502D773B4Q51817411-6DB1E596-8F15-41D0-BE40-DF3698A5E9B8Q52297939-B99E7187-5683-460A-8138-FE9C64DFEBC0Q57029714-03E40A0F-9EBE-4013-BEE3-5460323F4751Q59800025-62BBF989-4AC3-4FE2-9AAC-A699DF7BDC18Q61643380-0BE2B225-A95E-458D-AEDA-BEFD46629441Q64100042-AFC788DF-E9AA-47E6-B35B-1DE63C895053Q64121033-2875F786-B1D4-4872-9B17-45C9E7C6D85AQ64997765-2EF0C7D6-D4F0-4AC5-87B0-079E29EBCF44
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tomi Rantamäki
@ast
Tomi Rantamäki
@en
Tomi Rantamäki
@es
Tomi Rantamäki
@nl
Tomi Rantamäki
@sl
type
label
Tomi Rantamäki
@ast
Tomi Rantamäki
@en
Tomi Rantamäki
@es
Tomi Rantamäki
@nl
Tomi Rantamäki
@sl
prefLabel
Tomi Rantamäki
@ast
Tomi Rantamäki
@en
Tomi Rantamäki
@es
Tomi Rantamäki
@nl
Tomi Rantamäki
@sl
P106
P21
P31
P496
0000-0002-0052-1434
P569
2000-01-01T00:00:00Z